TARDBP and Alzheimer disease: Recently, the incorporation of non-conserved cryptic or ‘pseudo’ exons has been identified within brains that exhibit TDP-43 pathology including FTLD/ALS and Alzheimer’s disease with concomitant TDP-43 inclusions [115, 196].